Skip to main content

L350 (Desvenlafaxine Succinate Extended-Release 100 mg)

Pill with imprint L350 is Red, Round and has been identified as Desvenlafaxine Succinate Extended-Release 100 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Desvenlafaxine is used in the treatment of major depressive disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L350

Desvenlafaxine succinate extended-release 100 mg L350

Desvenlafaxine Succinate Extended-Release

100 mg
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
Inactive Ingredients
hypromelloses, microcrystalline cellulose, povidone k90, magnesium silicate, magnesium stearate, titanium dioxide, ferric oxide red, polyethylene glycol 8000, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "L350"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.